HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

arachidic acid

Also Known As:
arachidic acid, ammonium salt; arachidic acid, barium salt; arachidic acid, calcium salt; arachidic acid, magnesium salt; arachidic acid, potassium salt; arachidic acid, sodium salt; zinc arachidate
Networked: 17 relevant articles (0 outcomes, 4 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Cho, Hyun-Jong: 2 articles (04/2014 - 01/2013)
2. Kim, Dae-Duk: 2 articles (04/2014 - 01/2013)
3. Moon, Hyun Tae: 2 articles (04/2014 - 01/2013)
4. Termsarasab, Ubonvan: 2 articles (04/2014 - 01/2013)
5. Chen, Jianru: 1 article (01/2022)
6. Cui, Tingting: 1 article (01/2022)
7. Du, Pengran: 1 article (01/2022)
8. King, Irena B: 1 article (01/2022)
9. Lemaitre, Rozenn N: 1 article (01/2022)
10. Li, Baizhang: 1 article (01/2022)

Related Diseases

1. Type 2 Diabetes Mellitus (MODY)
01/01/2020 - "Very-long-chain SFAs (VLCSFAs), such as arachidic acid (20:0), behenic acid (22:0), and lignoceric acid (24:0), have demonstrated inverse associations with cardiometabolic conditions, although more evidence is needed to characterize their relation with risk of type 2 diabetes (T2D). "
11/01/2023 - "A unique group of circulating very-long-chain saturated fatty acids (VLCSFAs), including arachidic acid (20:0), behenic acid (22:0), and lignoceric acid (24:0), have been associated with a lower risk of type 2 diabetes, although associations with early metabolic risk phenotypes preceding type 2 diabetes have received limited study. "
01/01/2022 - "In contrast to other saturated fatty acids, very long-chain saturated fatty acids (VLSFAs) have received limited attention The purpose of this review is to summarize the associations of VLSFAs, including arachidic acid, behenic acid, and lignoceric acid, with cardiovascular disease outcomes and type 2 diabetes; to discuss the findings implications; and to call for future studies of the VLSFAs. "
10/01/2014 - "By contrast, measured odd-chain SFAs (15:0 [pentadecanoic acid] and 17:0 [heptadecanoic acid]) were inversely associated with incident type 2 diabetes (HR [95% CI] per 1 SD difference: 0·79 [0·73-0·85] for pentadecanoic acid and 0·67 [0·63-0·71] for heptadecanoic acid), as were measured longer-chain SFAs (20:0 [arachidic acid], 22:0 [behenic acid], 23:0 [tricosanoic acid], and 24:0 [lignoceric acid]), with HRs ranging from 0·72 to 0·81 (95% CIs ranging between 0·61 and 0·92). "
01/01/2022 - "Random-effects or fixed-effects models was used to estimate the pooled relative risks (RRs) and corresponding 95% confidence intervals (CIs) for the association of total or individual SFA biomarkers, including even-chain SFAs (e.g., 14:0, myristic acid; 16:0, palmitic acid; 18:0, stearic acid), odd-chain SFAs (e.g., 15:0, pentadecanoic acid; 17:0, margaric acid) and very-long-chain SFAs (VLCSFAs; e.g., 20:0, arachidic acid; 22:0, behenic acid; 24:0, lignoceric acid), with risk of incident type 2 diabetes (T2D), cardiovascular disease [CVD; coronary heart disease (CHD) inclusive of stroke], CHD and stroke. "
2. Atherosclerosis
3. Cardiovascular Diseases (Cardiovascular Disease)
4. Cognitive Dysfunction
5. Neoplasms (Cancer)

Related Drugs and Biologics

1. behenic acid (docosanoic acid)
2. lignoceric acid (tetracosanoic acid)
3. Fatty Acids (Saturated Fatty Acids)
4. alpha-Linolenic Acid (Linolenic Acid)
5. tricosanoic acid
6. Phospholipids (Phosphatides)
7. Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)
8. Cholesterol
9. 7-ketocholesterol
10. Chitosan

Related Therapies and Procedures

1. Therapeutics